Destiny Wealth Partners, LLC Viatris Inc Transaction History

Destiny Wealth Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$9.95 - $12.27 $1,184 - $1,460	-119 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$9.81 - $15.4 $1,981 - $3,110	-202 Reduced 62.93%	119 $1,000
Q4 2021 Jan 20, 2022	BUY	$12.09 - $14.68 $12 - $14	1 Added 0.31%	321 $4,000
Q3 2021 Oct 28, 2021	BUY	$13.25 - $15.13 $4,240 - $4,841	320 New	320 $4,000
Q2 2021 Jul 27, 2021	SELL	$12.97 - $16.15 $4,241 - $5,281	-327 Closed	0 $0
Q1 2021 Apr 22, 2021	SELL	$13.59 - $18.54 $67 - $92	-5 Reduced 1.51%	327 $5,000
Q4 2020 Feb 05, 2021	BUY	$14.3 - $18.74 $4,747 - $6,221	332 New	332 $6,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.